Morgan Stanley and Atlanta Capital Management Company, LLC filed Amendment No. 6 to Schedule 13G with the SEC on November 13, 2026, disclosing their combined beneficial ownership of Class A Common Stock in Dolby Laboratories, Inc. as of September 30, 2026.

Key Highlights

  • Morgan Stanley aggregate beneficial ownership: 3,044,622 shares of Dolby Laboratories Class A Common Stock, representing 5.1% of the class.
  • Atlanta Capital stake: Atlanta Capital Management Company, LLC reported aggregate beneficial ownership of 2,101,646 shares, representing 3.5% of the class.
  • Atlanta Capital below 5% threshold: According to the filing, "Atlanta Capital Management Company, LLC has ceased to be the beneficial owner of more than five percent of the class of securities."
  • Morgan Stanley shared voting power: 2,556,623 shares, with zero sole voting power reported.
  • Morgan Stanley shared dispositive power: 2,916,405 shares, with zero sole dispositive power reported.
  • Event date: The date of the event requiring this filing is stated as September 30, 2026.

Morgan Stanley and Atlanta Capital Disclose Dolby Class A Positions in Amended 13G

Morgan Stanley filed Amendment No. 6 to Schedule 13G on November 13, 2026, covering its beneficial ownership of Dolby Laboratories, Inc. (CUSIP 25659T107) Class A Common Stock as of September 30, 2026. According to the filing, Morgan Stanley, organized in Delaware and classified as a parent holding company and company (HC, CO), reported aggregate beneficial ownership of 3,044,622 shares, equal to 5.1% of the class. Morgan Stanley reported no sole voting or sole dispositive power, with shared voting power over 2,556,623 shares and shared dispositive power over 2,916,405 shares.

The filing also covers Atlanta Capital Management Company, LLC, based at 1075 Peachtree Street, Suite 2100, Atlanta, GA 30309, and classified as an investment adviser and company (IA, CO). Atlanta Capital reported aggregate beneficial ownership of 2,101,646 shares, or 3.5% of the class. The filing states that Atlanta Capital reported shared voting power of 1,783,136 shares and shared dispositive power of 1,983,934 shares, with no sole voting or dispositive power. The filing notes that Atlanta Capital has ceased to hold more than five percent of the class as of the filing date.

The filing was signed on November 13, 2026, by Claire Gordon as Authorized Signatory for Morgan Stanley and Kelly Williams as Authorized Signatory for Atlanta Capital Management Company, LLC. The filing certifies, in accordance with standard Schedule 13G language, that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." A joint filing agreement is listed as Exhibit 99.1 and subsidiary identification information as Exhibit 99.2.

What Was Disclosed

Morgan Stanley and Atlanta Capital Management Company, LLC filed an amended Schedule 13G disclosing their respective beneficial ownership positions in Dolby Laboratories Class A Common Stock as of September 30, 2026, with Morgan Stanley reporting 5.1% and Atlanta Capital reporting 3.5%.